Clinical Trial Update: A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia [Phase 2]

View source ↗

Summary

Phase 2 trial update showing results for intravenous Mircera in hemodialysis patients with anemia due to chronic kidney disease; results posted in December 2016…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 2 | Status: COMPLETED | Results posted: 2016-12-20